• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » COVID-19

COVID-19
COVID-19 RSS Feed RSS

WCG COVID-19 Resource Center Gives Trial Participants Key Information

April 5, 2020
WCG Clinical has launched a new COVID-19 online patient resource center to help trial participants understand how the pandemic may affect their trials and to help prospective participants match to clinical trials via CenterWatch iConnect. Read More

COVID-19 Update

April 5, 2020
COVID-19 Drug Research Roundup Read More
Protocol button

Consider Data Needs Carefully When Altering Trial Protocols in Response to COVID-19

April 5, 2020
Brandon May
To get through the COVID-19 crisis with their trials intact, sponsors and sites should take a new look at their data and data collection methods, including evaluating whether a trial will have enough reliable data to support a positive decision, finding ways to collect more data or using data monitoring committees (DMCs) to help assess and modify studies. Read More
QandA-360x240.png

FDA Adds Questions and Answers to Coronavirus Clinical Trial Guidance

April 5, 2020
James Miessler
The FDA has updated its guidance on conducting clinical trials during the COVID-19 pandemic with an extensive Q&A section, including a long list of factors to consider when deciding the status of ongoing trials and ones soon to be initiated, as well as how to obtain informed consent remotely. Read More

NLM Seeks Input on Improving ClinicalTrials.gov

April 1, 2020
ClinicalTrials.gov users will have a chance to weigh in on strategies for im­proving the database at a public meeting scheduled for April 30, which is likely to be held virtually because of the COVID-19 outbreak. Read More

Remote Monitoring, Protocol Amendments Spike With COVID-19 Spread

April 1, 2020
Brandon May

Protocol changes and deviations may be unavoidable to ensure the safety of trial participants during the COVID-19 crisis, the FDA says in a rare direct-to-final guidance released this week, and sponsors and investigators should examine alternatives to face-to-face trial procedures. 

Read More

Many Investigators Ceasing New Patient Enrollment, Survey Finds

March 29, 2020
A survey conducted by Clinical Research IO has found that 24 percent of investigators across 73 different research sites have stopped new patient enrollment due to concerns about COVID-19. Another 37 percent of investigators who responded to the survey say they are considering ceasing new patient enrollment due to COVID-19 safety concerns. Read More

UK Regulators to Only Conduct Essential Inspections During COVID-19 Outbreak

March 29, 2020
Regulators in the UK will only conduct essential on-site inspections of clinical trials, distribution, laboratories, manufacturing and pharmacovigilance during the COVID-19 outbreak, according to new guidances issued last week. Read More

EMA Guidance Calls for Systematic Planning of Trial Alterations

March 29, 2020
Sponsors of clinical trials in the EU should create a systematic plan for their COVID-19 response that documents reasons for protocol deviations and other trial adjustments, according to a new draft guidance from the EMA. Read More

Global Regulatory Workshop Offers Regulatory Considerations, Data Requirements for Phase 1 COVID-19 Vaccine Trials

March 29, 2020
A meeting report from a regulatory workshop held virtually under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA) provides an overview of new regulatory considerations for the development of COVID-19 vaccines and data requirements for phase 1 COVID-19 vaccine trials. Read More
Previous 1 2 … 14 15 16 17 18 19 20 21 22 Next

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing